281 related articles for article (PubMed ID: 16734820)
1. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
[TBL] [Abstract][Full Text] [Related]
2. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
3. Platelet ADP response deteriorates in synthetic storage media.
Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
[TBL] [Abstract][Full Text] [Related]
6. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
7. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Goto S; Tamura N; Ishida H; Ruggeri ZM
J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
[TBL] [Abstract][Full Text] [Related]
8. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
10. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation.
Kälvegren H; Skoglund C; Helldahl C; Lerm M; Grenegård M; Bengtsson T
Thromb Haemost; 2010 Feb; 103(2):398-407. PubMed ID: 20024498
[TBL] [Abstract][Full Text] [Related]
12. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
Valeri CR; Macgregor H; Ragno G
Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
[TBL] [Abstract][Full Text] [Related]
13. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
14. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
16. Pre-steady state study of beta-adrenergic and purinergic receptor interaction in C6 cell membranes: undelayed balance between positive and negative coupling to adenylyl cyclase.
Valeins H; Merle M; Labouesse J
Mol Pharmacol; 1992 Dec; 42(6):1033-41. PubMed ID: 1336111
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of purine nucleotides on purinergic P2 platelet receptors by small angle light scattering].
Sakaev MR; Mindukshev IV; Lesiovskaia EE; Petrishchev NN; Krivchenko AI
Eksp Klin Farmakol; 2000; 63(3):65-9. PubMed ID: 10934601
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors.
Vigne P; Breittmayer JP; Frelin C
Br J Pharmacol; 1998 Oct; 125(4):675-80. PubMed ID: 9831901
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
Jones S; Evans RJ; Mahaut-Smith MP
Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
